LONDON, UK — May 2025
As inflation squeezes margins and global health systems demand more for less, a growing number of MedTech and Pharma leaders have quietly deployed a powerful new ally: Agentic AI, developed by healthtech innovator Vamstar.

Unlike traditional AI tools, Agentic AI doesn’t just analyze data. It acts.

Embedded directly into workflows like pricing, tender response, and market access strategy, Vamstar’s Agentic AI agents interpret context, predict commercial risks, and autonomously execute micro-decisions—replicating the kind of judgment calls once reserved for senior teams. The result? Faster market moves, leaner operations, and a sharper commercial edge in an industry where precision is profit.

“In this environment, being reactive isn’t good enough,” said Praful Mehta, CEO of Vamstar. “MedTechs and Pharmas are under enormous pressure to compete on value, not just product. Agentic AI gives them an edge—not by replacing teams, but by giving every function superpowers.”

From overwhelmed to optimized

Procurement teams using Agentic AI can now process 10x more tenders with zero headcount increase. Market access leads are using it to map complex policy shifts and payer requirements in real time. Commercial teams are predicting net pricing pressure months in advance—backed by live data and AI-generated evidence dossiers.

Vamstar’s solution is already powering decision-making for several global firms—though many are keeping its use confidential to protect competitive advantage.

“It’s the AI you don’t see—but it’s already rewriting playbooks.”